We used the human RNF43 WT or 117fs-overexpressing CT26 cell lines, and compared with control tumours, human RNF43 WT-overexpressing tumours demonstrated reduced growth and improved response to an anti-PD-1 mAb (Fig. 3a). The gene discussed is RNF43; the disease is neoplasm.